CAR T cell immunotherapy for lymphoma rejected in Scotland
Patients living with an aggressive form of lymphoma in Scotland will not get routine access to a new immunotherapy treatment after it was rejected for use on the NHS.
Mar 14, 2019
0
3
Patients living with an aggressive form of lymphoma in Scotland will not get routine access to a new immunotherapy treatment after it was rejected for use on the NHS.
Mar 14, 2019
0
3
The use of textured breast implants during augmentation or reconstructive surgery can slightly increase a patient's risk of developing Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), a form of cancer ...
Mar 12, 2019
0
3
A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis. It can be important to adapt early on as to what treatment to ...
Mar 7, 2019
0
1
For just the second time ever an HIV patient is in sustained remission from the virus in what was hailed by experts Tuesday as proof that the AIDS-causing condition could one day be curable.
Mar 5, 2019
0
562
Healthy white blood cells, called "T-cells," play a crucial role in how the body fights follicular lymphoma. That's according to the results of a study led by Mayo Clinic hematologists Zhi Zhang Yang, M.D., and Stephen Ansell, ...
Feb 20, 2019
0
60
Many patients with lymphoma take longer to be diagnosed than expected, with some thinking these delays could have been avoided, a new report from the University of York has found.
Jan 29, 2019
0
0
People with a certain type of lymphoma will not be able to receive a targeted cancer drug on the NHS in England.
Dec 21, 2018
0
3
New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk of developing various types of solid tumors many years later. In addition, certain subgroups of patients have an especially ...
Dec 17, 2018
0
43
(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincristine, and prednisone ...
Dec 5, 2018
0
0
University of North Carolina Lineberger Comprehensive Cancer Center researchers reported promising early results from a clinical study of an investigational cellular immunotherapy that used a patient's own, genetically engineered ...
Dec 3, 2018
0
3